VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells

Neuro-Oncology

Volumn 17, Issue 3, 2015, Pages 407-418

  Chen, Yuanyuan ^a   Meng, Delong ^a   Wang, Huibo ^c   Sun, Ruochuan ^d   Wang, Dongrui ^a   Wang, Shuai ^c   Fan, Jiajun ^b   Zhao, Yingjie ^a   Wang, Jingkun ^a   Yang, Song ^d   Huai, Cong ^a   Song, Xiao ^a   Qin, Rong ^f   Xu, Tao ^f   Yun, Dapeng ^a   Hu, Lingna ^a   Yang, Jingmin ^a   Zhang, Xiaotian ^e   Chen, Haoming ^a   Chen, Juxiang ^f   Chen, Hongyan ^a   Lu, Daru ^a   more..

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Glioma; Proliferation; TMZ resistance; VAMP8

Indexed keywords

AUTOPHAGY PROTEIN 5; ONCOPROTEIN; SYNTAXIN; SYNTAXIN 17; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VESICLE ASSOCIATED MEMBRANE PROTEIN 8; ALKYLATING AGENT; DACARBAZINE; SYNAPTOBREVIN; TUMOR MARKER; VAMP8 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GLIOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; VESICLE ASSOCIATED MEMBRANE PROTEIN 8 GENE; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; BRAIN NEOPLASMS; CELL CYCLE; DRUG RESISTANCE; METABOLISM; MORTALITY;

ANTINEOPLASTIC AGENTS, ALKYLATING; AUTOPHAGY; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; GLIOMA; HUMANS; ONCOGENE PROTEINS; R-SNARE PROTEINS;

EID: 84987630030     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou219     Document Type: Article

References (40)

1. Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15:(Suppl 2):ii1-56.
2. Van Meir EG, Hadjipanayis CG, Norden AD, et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60(3):166-193.
3. Peng RW, Abellan E, Fussenegger M. Differential effect of exocytic SNAREs on the production of recombinant proteins in mammalian cells. Biotechnol Bioeng. 2011;108(3):611-620.
4. Lau SK, Boutros PC, Pintilie M, et al. Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol. 2007; 25(35):5562-5569.
5. Hasan N, Hu C. Vesicle-associated membrane protein 2 mediates trafficking of alpha5beta1 integrin to the plasma membrane. Exp Cell Res. 2010;316(1):12-23.
6. Wong SH, Zhang T, Xu Y, et al. Endobrevin, a novel synaptobrevin/ VAMP-like protein preferentially associated with the early endosome. Mol Biol Cell. 1998;9(6):1549-1563.
7. Antonin W, Holroyd C, Tikkanen R, et al. The R-SNARE endobrevin/ VAMP-8 mediates homotypic fusion of early endosomes and late endosomes. Mol Biol Cell. 2000;11(10):3289-3298.
8. Antonin W, Holroyd C, Fasshauer D, et al. A SNARE complex mediating fusion of late endosomes defines conserved properties of SNARE structure and function. EMBO J. 2000; 19(23):6453-6464.
9. Zhu D, Zhang Y, Lam PP, et al. Dual role of VAMP8 in regulating insulin exocytosis and islet beta cell growth. Cell Metab. 2012; 16(2):238-249.
10. Zhao P, Yang L, Lopez JA, et al. Variations in the requirement for v-SNAREs in GLUT4 trafficking in adipocytes. J Cell Sci. 2009;122: (Pt 19):3472-3480.
11. Behrendorff N, Dolai S, Hong W, et al. Vesicle-associated membrane protein 8 (VAMP8) is a SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) selectively required for sequential granule-to-granule fusion. J Biol Chem. 2011;286(34):29627-29634.
12. Furuta N, Fujita N, Noda T, et al. Combinational soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins VAMP8 and Vti1b mediate fusion of antimicrobial and canonical autophagosomes with lysosomes. Mol Biol Cell. 2010; 21(6):1001-1010.
13. Itakura E, Kishi-Itakura C, Mizushima N. The hairpin-type tailanchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell. 2012;151(6):1256-1269.
14. Zhuang W, Li B, Long L, et al. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer. 2011;129(11):2720-2731.
15. Palumbo S, Pirtoli L, Tini P, et al. Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. J Cell Biochem. 2012;113(7):2308-2318.
16. Natsumeda M, Aoki H, Miyahara H, et al. Induction of autophagy in temozolomide treated malignant gliomas. Neuropathology. 2011; 31(5):486-493.
17. Knizhnik AV, Roos WP, Nikolova T, et al. Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage. PLoS One. 2013;8(1):e55665.
18. Cui Y, Wu J, Zong M, et al. Proteomic profiling in pancreatic cancer with and without lymph node metastasis. Int J Cancer. 2009; 124(7):1614-1621.
19. Ohuchida K, Mizumoto K, Ishikawa N, et al. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res. 2005; 11(21):7785-7793.
20. Wan Y, Fei XF, Wang ZM, et al. Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3. Chin J Cancer. 2012;31(4):207-214.
21. Malliri A, van Es S, Huveneers S, et al. The Rac exchange factor Tiam1 is required for the establishment and maintenance of cadherin-based adhesions. J Biol Chem. 2004;279(29): 30092-30098.
22. Fang KM, Yang CS, Lin TC, et al. Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells. Neuro Oncol. 2014;16(4):552-566.
23. Kijima N, Hosen N, Kagawa N, et al. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion. Neuro Oncol. 2012;14(10):1254-1264.
24. Wang H, Zhang SY, Wang S, et al. REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy. Neuro Oncol. 2009;11(6):790-802.
25. Fan J, Zeng X, Li Y, et al. Autophagy plays a critical role in ChLym-1-induced cytotoxicity of non-hodgkin's lymphoma cells. PLoS One. 2013;8(8):e72478.
26. Brunckhorst MK, Wang H, Lu R, et al. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis. Cancer Res. 2010;70(18):7283-7293.
27. Qian X, Long L, Shi Z, et al. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma. Biomaterials. 2014;35(7):2322-2335.
28. Li Y, Zhu H, Zeng X, et al. Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-beta in human glioma cells. Mol Neurobiol. 2013;47(3):1000-1010.
29. Renna M, Schaffner C, Winslow AR, et al. Autophagic substrate clearance requires activity of the syntaxin-5 SNARE complex. J Cell Sci. 2011;124(Pt 3):469-482.
30. McLendon R, Friedman A, Bigner D, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-1068.
31. Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8(4):445-544.
32. Yu L, Tumati V, Tseng SF, et al. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor. Neoplasia. 2012;14(12): 1203-1212.
33. Kanzawa T, Germano IM, Komata T, et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004;11(4):448-457.
34. Hashimoto D, Blauer M, Hirota M, et al. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs. Eur J Cancer. 2014;50(7): 1382-1390.
35. Gewirtz DA. The four faces of autophagy: implications for cancer therapy. Cancer Res. 2014;74(3):647-651.
36. Low SH, Li X, Miura M, et al. Syntaxin 2 and endobrevin are required for the terminal step of cytokinesis in mammalian cells. Dev Cell. 2003;4(5):753-759.
37. Schiel JA, Park K, Morphew MK, et al. Endocytic membrane fusion and buckling-induced microtubule severing mediate cell abscission. J Cell Sci. 2011;124(Pt 9):1411-1424.
38. Sun S, Lee D, Ho AS, et al. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Neuro Oncol. 2013;15(5):562-577.
39. Kitange GJ, Carlson BL, Schroeder MA, et al. Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Neuro Oncol. 2009;11(3):281-291.
40. Lin CJ, Lee CC, Shih YL, et al. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radic Biol Med. 2012;52(2): 377-391.